Sign In

Bell Zhong

Managing Director at Raymond James

Bell Zhong was a Managing Director at Raymond James, covering the biotechnology sector in the Health Care Investment Banking team.24 He joined Raymond James in 2020 from J.P. Morgan Securities, LLC, where he held the title of executive director for health care.4 With over 17 years of finance and investment banking experience, Zhong specialized in advising biotechnology and pharmaceutical companies on capital markets, mergers & acquisitions, and other strategic transactions.12

During his career, Zhong helped execute over $35 billion in equity and equity-linked transactions and more than $100 billion in M&A transactions for both private and public companies.13 At Raymond James, he focused on emerging and growth-oriented companies in the biotech space, valuing the opportunity to make a meaningful impact on clients working to improve patients' lives.2

As of September 2022, Bell Zhong left Raymond James to become the Chief Financial Officer at Neomorph, Inc., a venture-backed biotechnology company focused on developing innovative medicines against undruggable targets.35

Related Questions

What are Bell Zhong's key achievements at Raymond James?
How did Bell Zhong transition from J.P. Morgan to Raymond James?
What makes Bell Zhong's approach to investment banking unique?
How has Bell Zhong's experience in the biotech sector influenced his career?
What challenges has Bell Zhong faced in his career and how did he overcome them?
Bell Zhong
Bell Zhong, photo 1
Bell Zhong, photo 2
Add to my network

Location

New York, New York, United States